Randomized phase II/III study of intensified alkylating agent chemotherapy with peripheral blood progenitor cell support in the preoperative chemotherapy of breast tumors that are deficient for homologous recombination.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antineoplastics; Carboplatin; Cyclophosphamide; Doxorubicin; Thiotepa
- Indications Breast cancer
- Focus Therapeutic Use
- 22 Jan 2021 Biomarkers information updated
- 25 Jan 2012 Planned end date 1 Feb 2010 added as reported by ClinicalTrials.gov.
- 02 Nov 2010 Status changed from recruiting to discontinued.